18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer

Abstract

A 60-year-old woman diagnosed with clear cell endometrial carcinoma received neoadjuvant chemotherapy. However, the patient was inoperable and referred to our clinic to evaluate the extent of the disease. The patient underwent ¹⁸FDG PET/CT and ⁶⁸Ga-FAPI (fibroblast activated protein inhibitor)-04 PET/CT scans. ⁶⁸Ga-FAPI-04 PET/CT outperformed ¹⁸FDG PET/CT demonstrating higher uptake in the metastatic lesions.